Source: International Congress 2017 – Primary care management of asthma and COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
P. Honkoop (Leiden, Netherlands). Personalised prediction of future risk using early treatment response. 1602

Member's Comments

No comment yet.

Related content which might interest you: A simple score for future risk prediction in patients with controlled asthma who undergo a step-down guidelines-based strategy. Source: International Congress 2017 – Monitoring novel biomarkers in asthma Year: 2017 Primary prevention of asthma: from risk and protective factors to targeted strategies for prevention Source: Virtual Congress 2020 – Reducing the burden of asthma Year: 2020 Halotherapy and Covid-19: an oppinion for a possible future prevention approach Source: Virtual Congress 2021 – COVID – 19: treatments and predictive factors Year: 2021 An innovative risk score for prediction of asthma related adverse outcome Source: Annual Congress 2009 - Quality of treatment in primary respiratory care Year: 2009 Genetic variation as a predictor of smoking cessation success. A promising preventive and intervention tool for chronic respiratory diseases? Source: Eur Respir J 2009; 33: 468-480 Year: 2009 How does current knowledge on primarily hereditary risk factors for asthma and other lung diseases improve prevention, treatment and prognosis? Source: Annual Congress 2012 - Genetics and genomics in asthma and COPD: prediction and personalised medicine Year: 2012 Asthma-associated factors - Potential predictive markers for patients stratification, personalized treatments and prevention Source: International Congress 2016 – Asthma points to ponder Year: 2016 Known and emerging risk factors for asthma development: is prevention possible? Source: International Congress 2015 – Asthma: emerging risk factors and current management of the patient Year: 2015 Introducing a new prognostic instrument for long-term mortality prediction among COPD patients - the CADOT index. Source: International Congress 2019 – Advances in clinical management of COPD Year: 2019 How to better assess and predict disease progression and treatment response: home-based spirometry, biomarkers or …? Source: International Congress 2019 – High-tech in interstitial lung diseases: just hype and gadgets? Year: 2019 Are biomarkers helpful in sepsis for risk assessment or clinical trials? Source: Annual Congress 2011 - Molecular biomarkers at the bedside of critically ill patients Year: 2011 Sputum induction for assessment of biomarkers in early development of new drugs for respiratory disease in a proof of concept setting Source: International Congress 2016 – Airway biomarkers Year: 2016 Other options of prevention - the current state and the future Source: Annual Congress 2003 - Latent tuberculosis infection - preventive approaches Year: 2003 Harvesting biomarkers for early risk assessment Source: Annual Congress 2008 - New age lung carcinogenesis: clinical impact Year: 2008 Blood biomarker algorithms to guide COPD assessment and risk stratification Source: International Congress 2017 – Towards personalised medicine in COPD: biological and clinical phenotypes Year: 2017 Prevention: educational issues and recommendations for early recognition Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-22-7, page=89 Year: 2005 A study of organizational effectiveness: identifying variables that predict successful respiratory therapy education programs Source: Annual Congress 2006 - Assessments of impairment in adults and children, and airway clearance techniques Year: 2006 New and future developments of therapy for asthma in children Source: Eur Respir Mon 2012; 56: 224-234 Year: 2012